Pulse Biosciences (PLSE) revenue breakdown
By product, System Products is the largest at 80% of fiscal 2022 revenue; Cycle Units Products grew fastest, -39% a year over 1 years.
By region, North America is the largest at 74% of fiscal 2022 revenue; Rest of World grew fastest, -22% a year over 1 years.
Revenue by product
Fiscal years, as Pulse Biosciences reports them in its 10-K filings; fiscal 2022 total $700,000.
| Products | 2021 | 2022 | Share |
|---|---|---|---|
| System Products | $1M | $560,000 | 80% |
| Cycle Units Products | $229,000 | $140,000 | 20% |
Revenue by region
Fiscal years, as Pulse Biosciences reports them in its 10-K filings; fiscal 2022 total $700,000.
| Regions | 2021 | 2022 | Share |
|---|---|---|---|
| North America | $1M | $517,000 | 74% |
| Rest of World | $236,000 | $183,000 | 26% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PLSE.
Open PLSE in InvestinglyQuestions
Where does Pulse Biosciences make its money?
In fiscal 2022, by product: System Products $560,000, Cycle Units Products $140,000.
From Pulse Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.